NCT05426161View on ClinicalTrials.gov

The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 7, 2023

Primary Completion Date

April 23, 2024

Study Completion Date

April 23, 2024

Conditions
Chronic PainLower Extremity Wound
Interventions
DRUG

Botulinum Toxin A

Botulinum Toxin A (10 units per cm2 wound areal) will be injected subcutaneously around the wound (1-2 cm from wound edge) maximum 200 units at each injection time.The total dose of BoNTA is maximum 400 units. Patient will receive one or two treatments in total.

Trial Locations (1)

Unknown

Department of Dermatology and Copenhagen Wound Healing Center, Bispebjerg Hospital, Copenhagen

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER